FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packageus.nlm.vsac
Resource TypeValueSet
IdValueSet-2.16.840.1.113883.3.464.1003.110.11.1156.json
FHIR VersionR4
Sourcehttps://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.464.1003.110.11.1156/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1156
Version20240302
Statusactive
Date2024-03-02T01:18:41-05:00
NameHiBVaccine3DoseScheduleAdministered
TitleHiB Vaccine (3 dose schedule) Administered
Realmus
Authorityhl7
Purpose(Clinical Focus: The purpose of this value set is to represent concepts for a 3-dose haemophilus influenzae type b (Hib) vaccination.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a 3-dose haemophilus influenzae type b (Hib) vaccination.),(Exclusion Criteria: No exclusions.)

Resources that use this resource

ValueSet
2.16.840.1.113883.3.464.1003.110.12.1084Hib Vaccine (3 dose schedule) Administered

Resources that this resource uses

CodeSystem
sctSNOMED codes used in this IG

Narrative

No narrative content found in resource


Source1

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.110.11.1156",
  "meta": {
    "versionId": "16",
    "lastUpdated": "2024-03-02T01:18:41.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "NCQA PHEMUR Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-03-10"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2024-03-02"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1156",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.3.464.1003.110.11.1156"
    }
  ],
  "version": "20240302",
  "name": "HiBVaccine3DoseScheduleAdministered",
  "title": "HiB Vaccine (3 dose schedule) Administered",
  "status": "active",
  "date": "2024-03-02T01:18:41-05:00",
  "publisher": "NCQA PHEMUR",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for a 3-dose haemophilus influenzae type b (Hib) vaccination.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a 3-dose haemophilus influenzae type b (Hib) vaccination.),(Exclusion Criteria: No exclusions.)",
  "compose": {
    "include": [
      {
        "system": "http://snomed.info/sct",
        "concept": [
          {
            "code": "127787002",
            "display": "Administration of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
          },
          {
            "code": "170343007",
            "display": "Administration of first dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
          },
          {
            "code": "170344001",
            "display": "Administration of second dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
          },
          {
            "code": "170345000",
            "display": "Administration of third dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
          },
          {
            "code": "170346004",
            "display": "Administration of booster dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:7cb0bbf8-cbd7-4fc8-956b-17d2c7cc94a1",
    "timestamp": "2025-05-23T22:17:09-04:00",
    "total": 5,
    "contains": [
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "127787002",
        "display": "Administration of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "170343007",
        "display": "Administration of first dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "170344001",
        "display": "Administration of second dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "170345000",
        "display": "Administration of third dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "170346004",
        "display": "Administration of booster dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
      }
    ]
  }
}